Involvement of Vasopressin in Tissue Hypoperfusion during Cardiogenic Shock Complicating Acute Myocardial Infarction in Rats
Acute heart failure (AHF) due to acute myocardial infarction (AMI) is likely to involve cardiogenic shock (CS), with neuro-hormonal activation. A relationship between AHF, CS and vasopressin response is suspected. This study aimed to investigate the implication of vasopressin on hemodynamic paramete...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866678/ https://www.ncbi.nlm.nih.gov/pubmed/36674841 http://dx.doi.org/10.3390/ijms24021325 |
_version_ | 1784876151334764544 |
---|---|
author | Gaudard, Philippe David, Hélène Bideaux, Patrice Sicard, Pierre Cristol, Jean-Paul Guillon, Gilles Richard, Sylvain Colson, Pascal Virsolvy, Anne |
author_facet | Gaudard, Philippe David, Hélène Bideaux, Patrice Sicard, Pierre Cristol, Jean-Paul Guillon, Gilles Richard, Sylvain Colson, Pascal Virsolvy, Anne |
author_sort | Gaudard, Philippe |
collection | PubMed |
description | Acute heart failure (AHF) due to acute myocardial infarction (AMI) is likely to involve cardiogenic shock (CS), with neuro-hormonal activation. A relationship between AHF, CS and vasopressin response is suspected. This study aimed to investigate the implication of vasopressin on hemodynamic parameters and tissue perfusion at the early phase of CS complicating AMI. Experiments were performed on male Wistar rats submitted or not to left coronary artery ligation (AMI and Sham). Six groups were studied Sham and AMI treated or not with either a vasopressin antagonist SR-49059 (Sham-SR, AMI-SR) or agonist terlipressin (Sham-TLP, AMI-TLP). Animals were sacrificed one day after surgery (D(1)) and after hemodynamic parameters determination. Vascular responses to vasopressin were evaluated, ex vivo, on aorta. AHF was defined by a left ventricular ejection fraction below 40%. CS was defined by AHF plus tissue hypoperfusion evidenced by elevated serum lactate level or low mesenteric oxygen saturation (SmO(2)) at D(1). Mortality rates were 40% in AMI, 0% in AMI-SR and 33% in AMI-TLP. Immediately after surgery, a sharp decrease in SmO(2) was observed in all groups. At D(1), SmO(2) recovered in Sham and in SR-treated animals while it remained low in AMI and further decreased in TLP-treated groups. The incidence of CS among AHF animals was 72% in AMI or AMI-TLP while it was reduced to 25% in AMI-SR. Plasma copeptin level was increased by AMI. Maximal contractile response to vasopressin was decreased in AMI (32%) as in TLP- and SR- treated groups regardless of ligation. Increased vasopressin secretion occurring in the early phase of AMI may be responsible of mesenteric hypoperfusion resulting in tissue hypoxia. Treatment with a vasopressin antagonist enhanced mesenteric perfusion and improve survival. This could be an interesting therapeutic strategy to prevent progression to cardiogenic shock. |
format | Online Article Text |
id | pubmed-9866678 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98666782023-01-22 Involvement of Vasopressin in Tissue Hypoperfusion during Cardiogenic Shock Complicating Acute Myocardial Infarction in Rats Gaudard, Philippe David, Hélène Bideaux, Patrice Sicard, Pierre Cristol, Jean-Paul Guillon, Gilles Richard, Sylvain Colson, Pascal Virsolvy, Anne Int J Mol Sci Article Acute heart failure (AHF) due to acute myocardial infarction (AMI) is likely to involve cardiogenic shock (CS), with neuro-hormonal activation. A relationship between AHF, CS and vasopressin response is suspected. This study aimed to investigate the implication of vasopressin on hemodynamic parameters and tissue perfusion at the early phase of CS complicating AMI. Experiments were performed on male Wistar rats submitted or not to left coronary artery ligation (AMI and Sham). Six groups were studied Sham and AMI treated or not with either a vasopressin antagonist SR-49059 (Sham-SR, AMI-SR) or agonist terlipressin (Sham-TLP, AMI-TLP). Animals were sacrificed one day after surgery (D(1)) and after hemodynamic parameters determination. Vascular responses to vasopressin were evaluated, ex vivo, on aorta. AHF was defined by a left ventricular ejection fraction below 40%. CS was defined by AHF plus tissue hypoperfusion evidenced by elevated serum lactate level or low mesenteric oxygen saturation (SmO(2)) at D(1). Mortality rates were 40% in AMI, 0% in AMI-SR and 33% in AMI-TLP. Immediately after surgery, a sharp decrease in SmO(2) was observed in all groups. At D(1), SmO(2) recovered in Sham and in SR-treated animals while it remained low in AMI and further decreased in TLP-treated groups. The incidence of CS among AHF animals was 72% in AMI or AMI-TLP while it was reduced to 25% in AMI-SR. Plasma copeptin level was increased by AMI. Maximal contractile response to vasopressin was decreased in AMI (32%) as in TLP- and SR- treated groups regardless of ligation. Increased vasopressin secretion occurring in the early phase of AMI may be responsible of mesenteric hypoperfusion resulting in tissue hypoxia. Treatment with a vasopressin antagonist enhanced mesenteric perfusion and improve survival. This could be an interesting therapeutic strategy to prevent progression to cardiogenic shock. MDPI 2023-01-10 /pmc/articles/PMC9866678/ /pubmed/36674841 http://dx.doi.org/10.3390/ijms24021325 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gaudard, Philippe David, Hélène Bideaux, Patrice Sicard, Pierre Cristol, Jean-Paul Guillon, Gilles Richard, Sylvain Colson, Pascal Virsolvy, Anne Involvement of Vasopressin in Tissue Hypoperfusion during Cardiogenic Shock Complicating Acute Myocardial Infarction in Rats |
title | Involvement of Vasopressin in Tissue Hypoperfusion during Cardiogenic Shock Complicating Acute Myocardial Infarction in Rats |
title_full | Involvement of Vasopressin in Tissue Hypoperfusion during Cardiogenic Shock Complicating Acute Myocardial Infarction in Rats |
title_fullStr | Involvement of Vasopressin in Tissue Hypoperfusion during Cardiogenic Shock Complicating Acute Myocardial Infarction in Rats |
title_full_unstemmed | Involvement of Vasopressin in Tissue Hypoperfusion during Cardiogenic Shock Complicating Acute Myocardial Infarction in Rats |
title_short | Involvement of Vasopressin in Tissue Hypoperfusion during Cardiogenic Shock Complicating Acute Myocardial Infarction in Rats |
title_sort | involvement of vasopressin in tissue hypoperfusion during cardiogenic shock complicating acute myocardial infarction in rats |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866678/ https://www.ncbi.nlm.nih.gov/pubmed/36674841 http://dx.doi.org/10.3390/ijms24021325 |
work_keys_str_mv | AT gaudardphilippe involvementofvasopressinintissuehypoperfusionduringcardiogenicshockcomplicatingacutemyocardialinfarctioninrats AT davidhelene involvementofvasopressinintissuehypoperfusionduringcardiogenicshockcomplicatingacutemyocardialinfarctioninrats AT bideauxpatrice involvementofvasopressinintissuehypoperfusionduringcardiogenicshockcomplicatingacutemyocardialinfarctioninrats AT sicardpierre involvementofvasopressinintissuehypoperfusionduringcardiogenicshockcomplicatingacutemyocardialinfarctioninrats AT cristoljeanpaul involvementofvasopressinintissuehypoperfusionduringcardiogenicshockcomplicatingacutemyocardialinfarctioninrats AT guillongilles involvementofvasopressinintissuehypoperfusionduringcardiogenicshockcomplicatingacutemyocardialinfarctioninrats AT richardsylvain involvementofvasopressinintissuehypoperfusionduringcardiogenicshockcomplicatingacutemyocardialinfarctioninrats AT colsonpascal involvementofvasopressinintissuehypoperfusionduringcardiogenicshockcomplicatingacutemyocardialinfarctioninrats AT virsolvyanne involvementofvasopressinintissuehypoperfusionduringcardiogenicshockcomplicatingacutemyocardialinfarctioninrats |